Table 2.
Subdivision of COVID-19 Mild patients by outcome in “survivors” and “non-survivors”; CAD: coronary artery diseases; HF: heart failure; PAD: peripheral artery disease; CKD: chronic kidney disease; COPD: Chronic obstructive pulmonary disease.
| Mild “survivors” (37) | Mild “non-survivors” (8) | p-value | |
|---|---|---|---|
| Sex | F: 19 (51%); M: 18 (49%) | F: 3 (37.5%); M: 5 (62.5%) | 0.489 |
| Age | 65.24 ± 17.33 | 80.25 ± 10.37 | 0.024 |
| CAD | 5 (13.5%) | 2 (25.0%) | 0.307 |
| HF | 3 (8.1%) | 1 (12.5%) | 0.637 |
| Obesity | 4 (10.8%) | – | 0.317 |
| Atrial Fibrillation | 4 (10.8%) | 2 (25.0%) | 0.355 |
| Valvular disease | – | 1 (12.5%) | 0.040 |
| PAD | – | 1 (12.5%) | 0.008 |
| Dyslipidemia | 4 (10.8%) | 2 (25.0%) | 0.201 |
| Diabetes mellitus | 12 (32.4%) | 2 (25.0%) | 0.835 |
| Arterial hypertension | 22 (59.5%) | 4 (50.0%) | 0.364 |
| CKD | 4 (10.8%) | 3 (37.5%) | 0.195 |
| Smoking | 1 (2.7%) | 2 (25.0%) | 0.006 |
| COPD | 6 (16.2%) | 4 (50.0%) | 0.014 |
| Autoimmune disease | 1 (2.7%) | 2 (25.0%) | 0.700 |